Description
Diabetes
is reportedly the fourth leading cause of death globally. Europe has close to
60 million people affected with diabetes, with the number purported to grow
annually. The Middle East and Africa regions have recently registered a high
percentage of the population afflicted with type II diabetes. Diabetic care
devices can be used to track hypoglycemic and hyperglycemic levels among
patients
Request Free Sample Copy - https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-diabetes-care-devices-industry-2017/request-sample
Insulin
pumps, insulin syringes, insulin pens, self-monitoring blood glucose meters,
continuous glucose meters, lancets, and testing strips are devices used in
management of diabetes. Manufacturers of these devices are increasingly
improving the technology in order to gain precise results. Merck KGaA has
launched a diabetes awareness program in the Middle East, called Merck Capacity
Advancement Program, in collaboration with the Emirates Diabetes Society to decrease
the prevalence of diabetes in the region.
Diabetes Management Solutions
Insulin
pens are used by diabetics for timely delivery of insulin for treating this
disease. Novo Nordisk, one of the market players, has expanded its reach in
Ghana by launching the Flexpen, an insulin pen. The pen can deliver accurate
doses at appropriate times and alleviate the burden on diabetic patients
residing in the country.
Due
to the prominence of smart technologies, Roche Diagnostics has launched the
Accu-Chek Guide System, a blood glucose meter (BGM) that can be used by
patients to track blood sugar levels. Medtronic plc, another healthcare
solutions provider, has collaborated with Roche to integrate their BGM
technology with its proprietary insulin pumps
View Full Report at- https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-diabetes-care-devices-industry-2017
Market Outlook
The
diabetic care devices market in EMEA is projected to expand at a steady growth
rate during the forecast period (2012–2022). Growing cases of diabetes among
people in Europe, Africa, and the Middle East regions is a major factor driving
market demand. Need for safe and effective methods to deliver drugs or
appropriate medicine to control blood sugar levels is also expected to
influence market growth. Patent expiration of some devices and changes in regulations
are some of the challenges in the market. Awareness of consumers regarding
benefits of these devices is predicted to augur product sales.
Key
market participants include Johnson & Johnson, Roche Diagnostics, Ypsomed
Holding, and Bayer HealthCare Pharmaceuticals LLC
About Us
Radiant
Insights is a market research and consulting company offering syndicated
research studies, customized reports, and consulting services. Our market
research studies are designed to facilitate strategic decision making, on the
basis of extensive and in-depth quantitative information, supported by
extensive analysis and industry insights. Using a patented and robust research
methodology, we publish exhaustive research reports covering a host of
industries such as Technology, Chemicals, Materials, and Energy. Radiant
Insights has a strong base of analysts, consultants and domain experts, with
global experience helping us deliver excellence in all research projects we
undertake
Contact Us
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
201
Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel:
1-415-349-0054
Toll
Free: 1-888-928-9744
No comments:
Post a Comment